Skip to main content

Advertisement

Fig. 4 | EJNMMI Research

Fig. 4

From: Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Fig. 4

Pre-treatment with ENZ increases 177Lu-PSMA617-induced DNA damage. Phospho-γH2A.X levels were flow cytometrically quantified in FNA tumor biopsies 4 h, 48 h, and 96 h following administration of 177Lu-PSMA617 or vehicle, respectively. The fold-change in phospho-γH2A.X compared to baseline (day before RLT) is shown as mean ± SD. Asterisks indicate significance in ENZ+RLT-treated tumors compared to baseline (ENZ+RLT: 0 vs. 4 h, p = 0.003; 0 vs. 48 h, p < 0.0001)

Back to article page